Reports Show Weaknesses in Oversight of Clinical Trials

ProPublica: Millions of Americans enroll in clinical trials for experimental drugs and medical devices every year, essentially putting their well-being in the hands of the medical boards that oversee them. But two recent reports raise troubling concerns about these institutional review boards, or IRBs, and point to gaps in federal oversight.
(Read the article>)